Insulin-Like Growth Factor I (IGF-1) Ec/Mechano Growth Factor - A Splice Variant of IGF-1 within the Growth Plate

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Schlegel, Werner ^a   Raimann, Adalbert ^a   Halbauer, Daniel ^a   Scharmer, Daniela ^b   Sagmeister, Susanne ^a   Wessner, Barbara ^c   Helmreich, Magdalena ^b   Haeusler, Gabriele ^b   Egerbacher, Monika ^b  

^a UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; SOMATOMEDIN C;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARTILAGE CELL; CELL CULTURE; CELL PROLIFERATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOPLASM; DNA SYNTHESIS; EXON; GENE LOCUS; GROWTH PLATE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; MUSCULOSKELETAL FUNCTION; NONHUMAN; PIGLET; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CELL NUCLEUS; CELL PROLIFERATION; CHONDROCYTES; CYTOSOL; GENE EXPRESSION; GROWTH PLATE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MECHANOTRANSDUCTION, CELLULAR; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; PEPTIDES; PRIMARY CELL CULTURE; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SWINE;

EID: 84885405035     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076133     Document Type: Article

References (68)

1. Green H, Morikawa M, Nixon T, (1985) A dual effector theory of growth-hormone action. Differentiation 29: 195-198.
2. Hunziker EB, Wagner J, Zapf J, (1994) Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. J Clin Invest 93: 1078-1086.
3. Isaksson OG, Lindahl A, Nilsson A, Isgaard J, (1987) Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 8: 426-438.
4. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A, (2001) The somatomedin hypothesis: 2001. Endocr Rev 22: 53-74.
5. Govoni KE, Lee SK, Chung YS, Behringer RR, Wergedal JE, et al. (2007) Disruption of insulin-like growth factor-I expression in type IIalphaI collagen-expressing cells reduces bone length and width in mice. Physiol Genomics 30: 354-362.
6. Adamo ML, Ben-Hur H, Roberts CT Jr, LeRoith D, (1991) Regulation of start site usage in the leader exons of the rat insulin-like growth factor-I gene by development, fasting, and diabetes. Mol Endocrinol 5: 1677-1686.
7. Dickson MC, Saunders JC, Gilmour RS, (1991) The ovine insulin-like growth factor-I gene: characterization, expression and identification of a putative promoter. J Mol Endocrinol 6: 17-31.
8. Saunders JC, Dickson MC, Pell JM, Gilmour RS, (1991) Expression of a growth hormone-responsive exon of the ovine insulin-like growth factor-I gene. J Mol Endocrinol 7: 233-240.
9. Lowe WL Jr, Lasky SR, LeRoith D, Roberts CT Jr, (1988) Distribution and regulation of rat insulin-like growth factor I messenger ribonucleic acids encoding alternative carboxyterminal E-peptides: evidence for differential processing and regulation in liver. Mol Endocrinol 2: 528-535.
10. Rinderknecht E, Humbel RE, (1978) The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253: 2769-2776.
11. Rotwein P, Pollock KM, Didier DK, Krivi GG, (1986) Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. J Biol Chem 261: 4828-4832.
12. Brisson BK, Barton ER, (2012) Insulin-like growth factor-I E-peptide activity is dependent on the IGF-I receptor. PLoS One 7: e45588.
13. Conover CA, Baker BK, Bale LK, Clarkson JT, Liu F, et al. (1993) Human hepatoma cells synthesize and secrete insulin-like growth factor Ia prohormone under growth hormone control. Regul Pept 48: 1-8.
14. Conover CA, Baker BK, Hintz RL, (1989) Cultured human fibroblasts secrete insulin-like growth factor IA prohormone. J Clin Endocrinol Metab 69: 25-30.
15. Wilson HE, Westwood M, White A, Clayton PE, (2001) Monoclonal antibodies to the carboxy-terminal Ea sequence of pro-insulin-like growth factor-IA (proIGF-IA) recognize proIGF-IA secreted by IM9 B-lymphocytes. Growth Horm IGF Res 11: 10-17.
16. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R, (1993) A C. elegans mutant that lives twice as long as wild type. Nature 366: 461-464.
17. Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, et al. (2003) Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424: 277-283.
18. Chan SJ, Steiner DF, (2000) Insulin through the ages: Phylogeny of a growth promoting and metabolic regulatory hormone. American Zoologist 40: 213-222.
19. McKoy G, Ashley W, Mander J, Yang SY, Williams N, et al. (1999) Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J Physiol 516 (Pt 2): 583-592.
20. Dluzniewska J, Sarnowska A, Beresewicz M, Johnson I, Srai SK, et al. (2005) A strong neuroprotective effect of the autonomous C-terminal peptide of IGF-1 Ec (MGF) in brain ischemia. Faseb J 19: 1896-1898.
21. Philippou A, Stavropoulou A, Sourla A, Pissimissis N, Halapas A, et al. (2008) Characterization of a rabbit antihuman mechano growth factor (MGF) polyclonal antibody against the last 24 amino acids of the E domain. In Vivo 22: 27-35.
22. Yang S, Alnaqeeb M, Simpson H, Goldspink G, (1996) Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. J Muscle Res Cell Motil 17: 487-495.
23. Yang SY, Goldspink G, (2002) Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett 522: 156-160.
24. Milingos DS, Philippou A, Armakolas A, Papageorgiou E, Sourla A, et al. (2011) Insulinlike growth factor-1Ec (MGF) expression in eutopic and ectopic endometrium: characterization of the MGF E-peptide actions in vitro. Mol Med 17: 21-28.
25. Milingos D, Katopodis H, Milingos S, Protopapas A, Creatsas G, et al. (2006) Insulin-like growth factor-1 isoform mRNA expression in women with endometriosis: eutopic endometrium versus endometriotic cyst. Ann N Y Acad Sci 1092: 434-439.
26. Goldspink G, (1996) Muscle growth and muscle function: a molecular biological perspective. Res Vet Sci 60: 193-204.
27. Burniston JG, Chester N, Clark WA, Tan LB, Goldspink DF, (2005) Dose-dependent apoptotic and necrotic myocyte death induced by the beta2-adrenergic receptor agonist, clenbuterol. Muscle Nerve 32: 767-774.
28. Tang LL, Xian CY, Wang YL, (2006) The MGF expression of osteoblasts in response to mechanical overload. Arch Oral Biol 51: 1080-1085.
29. Xin C, Bingbing Z, Yuanliang W, Chengyu X, Li Y, et al. (2012) Mechano-growth factor E peptide inhibits the differentiation and mineralization of osteoblasts. Arch Oral Biol 57: 720-727.
30. Deng M, Zhang B, Wang K, Liu F, Xiao H, et al. (2011) Mechano growth factor E peptide promotes osteoblasts proliferation and bone-defect healing in rabbits. Int Orthop 35: 1099-1106.
31. Heinemeier KM, Olesen JL, Haddad F, Schjerling P, Baldwin KM, et al. (2009) Effect of unloading followed by reloading on expression of collagen and related growth factors in rat tendon and muscle. J Appl Physiol 106: 178-186.
32. Heinemeier KM, Olesen JL, Schjerling P, Haddad F, Langberg H, et al. (2007) Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and tendon: differential effects of specific contraction types. J Appl Physiol 102: 573-581.
33. Langenskiold A, (1998) Role of the ossification groove of Ranvier in normal and pathologic bone growth: a review. J Pediatr Orthop 18: 173-177.
34. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K, (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80: 3689-3698.
35. van der Eerden BC, Karperien M, Wit JM, (2001) The estrogen receptor in the growth plate: implications for pubertal growth. J Pediatr Endocrinol Metab 14Suppl 6: 1527-1533.
36. Thurston MN, Kember NF, (1985) In vitro thymidine labelling in human and porcine growth plates. Cell Tissue Kinet 18: 575-582.
37. Gohring AR, Lubke C, Andreas K, Kaps C, Haupl T, et al. (2010) Tissue-engineered cartilage of porcine and human origin as in vitro test system in arthritis research. Biotechnol Prog 26: 1116-1125.
38. Pearce AI, Richards RG, Milz S, Schneider E, Pearce SG, (2007) Animal models for implant biomaterial research in bone: a review. Eur Cell Mater 13: 1-10.
39. Gotterbarm T, Breusch SJ, Schneider U, Jung M, (2008) The minipig model for experimental chondral and osteochondral defect repair in tissue engineering: retrospective analysis of 180 defects. Lab Anim 42: 71-82.
40. Connolly SA, Jaramillo D, Hong JK, Shapiro F, (2004) Skeletal development in fetal pig specimens: MR imaging of femur with histologic comparison. Radiology 233: 505-514.
41. Albrecht C, Helmreich M, Tichy B, Marlovits S, Plasenzotti R, et al. (2009) Impact of 3D-culture on the expression of differentiation markers and hormone receptors in growth plate chondrocytes as compared to articular chondrocytes. Int J Mol Med 23: 347-355.
42. Schlegel W, Halbauer D, Raimann A, Albrecht C, Scharmer D, et al. (2010) IGF expression patterns and regulation in growth plate chondrocytes. Mol Cell Endocrinol 327: 65-71.
43. Marlovits S, Hombauer M, Tamandl D, Vecsei V, Schlegel W, (2004) Quantitative analysis of gene expression in human articular chondrocytes in monolayer culture. Int J Mol Med 13: 281-287.
44. Loeser RF, Shanker G, Carlson CS, Gardin JF, Shelton BJ, et al. (2000) Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis: studies in a non-human primate model of naturally occurring disease. Arthritis Rheum 43: 2110-2120.
45. Benya PD, Padilla SR, (1993) Dihydrocytochalasin B enhances transforming growth factor-beta-induced reexpression of the differentiated chondrocyte phenotype without stimulation of collagen synthesis. Exp Cell Res 204: 268-277.
46. Albrecht C, Schlegel W, Bartko P, Eckl P, Jagersberger T, et al. (2010) Changes in the endogenous BMP expression during redifferentiation of chondrocytes in 3D cultures. Int J Mol Med 26: 317-323.
47. Savendahl L, (2005) Hormonal regulation of growth plate cartilage. Horm Res 64Suppl 2: 94-97.
48. Perry RJ, Farquharson C, Ahmed SF, (2008) The role of sex steroids in controlling pubertal growth. Clin Endocrinol (Oxf) 68: 4-15.
49. Nilsson O, Marino R, De Luca F, Phillip M, Baron J, (2005) Endocrine regulation of the growth plate. Horm Res 64: 157-165.
50. Owino V, Yang SY, Goldspink G, (2001) Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload. FEBS Lett 505: 259-263.
51. Goldspink G, (2005) Mechanical signals, IGF-I gene splicing, and muscle adaptation. Physiology (Bethesda) 20: 232-238.
52. Siegfried JM, Kasprzyk PG, Treston AM, Mulshine JL, Quinn KA, et al. (1992) A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone. Proc Natl Acad Sci U S A. 8107-8111.
53. Ates K, Yang SY, Orrell RW, Sinanan AC, Simons P, et al. (2007) The IGF-I splice variant MGF increases progenitor cells in ALS, dystrophic, and normal muscle. FEBS Lett 581: 2727-2732.
54. Mills P, Dominique JC, Lafreniere JF, Bouchentouf M, Tremblay JP, (2007) A synthetic mechano growth factor E Peptide enhances myogenic precursor cell transplantation success. Am J Transplant 7: 2247-2259.
55. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR, (1997) The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 272: 6653-6662.
56. Stavropoulou A, Halapas A, Sourla A, Philippou A, Papageorgiou E, et al. (2009) IGF-1 expression in infarcted myocardium and MGF E peptide actions in rat cardiomyocytes in vitro. Mol Med 15: 127-135.
57. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, et al. (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI (3) K/Akt/mTOR and PI (3) K/Akt/GSK3 pathways. Nat Cell Biol 3: 1009-1013.
58. Moschos MM, Armakolas A, Philippou A, Pissimissis N, Panteleakou Z, et al. (2011) Expression of the insulin-like growth factor 1 (IGF-1) and type I IGF receptor mRNAs in human HLE-B3 lens epithelial cells. In Vivo 25: 179-184.
59. Tan DS, Cook A, Chew SL, (2002) Nucleolar localization of an isoform of the IGF-I precursor. BMC Cell Biol 3: 17.
60. Dai Z, Wu F, Yeung EW, Li Y, (2010) IGF-IEc expression, regulation and biological function in different tissues. Growth Horm IGF Res 20: 275-281.
61. Manes S, Kremer L, Albar JP, Mark C, Llopis R, et al. (1997) Functional epitope mapping of insulin-like growth factor I (IGF-I) by anti-IGF-I monoclonal antibodies. Endocrinology 138: 905-915.
62. Annunziata M, Granata R, Ghigo E, (2011) The IGF system. Acta Diabetol 48: 1-9.
63. LeRoith D, Roberts CT Jr, (2003) The insulin-like growth factor system and cancer. Cancer Lett 195: 127-137.
64. Lewis DA, Travers JB, Spandau DF, (2009) A new paradigm for the role of aging in the development of skin cancer. J Invest Dermatol 129: 787-791.
65. Cohen E, Dillin A, (2008) The insulin paradox: aging, proteotoxicity and neurodegeneration. Nat Rev Neurosci 9: 759-767.
66. Cohen E, Du D, Joyce D, Kapernick EA, Volovik Y, et al. (2010) Temporal requirements of insulin/IGF-1 signaling for proteotoxicity protection. Aging Cell 9: 126-134.
67. Kaletsky R, Murphy CT, (2010) The role of insulin/IGF-like signaling in C. elegans longevity and aging. Dis Model Mech 3: 415-419.
68. Wilsman NJ, Farnum CE, Leiferman EM, Fry M, Barreto C (1996) Differential growth by growth plates as a function of multiple parameters of chondrocytic kinetics. Journal of orthopaedic research: official publication of the Orthopaedic Research Society 14: 927-936.